This antibiotic ointment is applied to the skin to prevent minor cuts, scrapes, and burns from becoming infected by stopping bacterial growth.[1] Baciguent is currently being investigated across 1 indication[3], with its most advanced program in Preclinical.[1]
Baciguent is one of 3 small molecule programs targeting Sinus Surgery. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2 competitors in Sinus Surgery
Nucala
Intuniv
Baciguent
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details